CEP55 Antibodies

Santa Cruz Biotechnology offers a broad range of CEP55 monoclonal antibodies for research in cell division and cytokinesis. CEP55 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CEP55, or centrosomal protein 55, plays a critical role in the final stages of cell division, particularly in the abscission process that separates daughter cells. Its proper function is essential for maintaining genomic stability and preventing tumorigenesis, making CEP55 a significant target in cancer research. Understanding CEP55 in cellular processes can provide insights into potential therapeutic strategies for various malignancies. Researchers worldwide rely on CEP55 monoclonal antibodies to advance their studies in cell biology and cancer research. The extensive applications of CEP55 monoclonal antibodies enable detailed investigation of cellular mechanisms and pathways. CEP55 monoclonal antibodies from Santa Cruz Biotechnology continue to support breakthrough discoveries in cell division research and cancer biology.